HealthEquity Sees Bright Gains as Stock Closes at $102.40
HealthEquity (HQY) shares jumped 3.5% during the last trading session, finishing at $102.40. This increase came with significant trading volume, surpassing typical levels. In comparison, the stock has gained 12.9% in the last four weeks.
Solid Financial Performance Fuels Investor Optimism
The surge in HQY shares stems from positive market outlook due to the company’s robust recent financial results and a solid underlying business model. Year-to-date, HealthEquity has seen an impressive return of 55%. Investors are optimistic about the company’s continued growth in earnings and revenue, which are expected to be affirmed in upcoming results.
Upcoming Earnings Report Shows Promising Numbers
HealthEquity is anticipated to report quarterly earnings of $0.71 per share in its next financial disclosure, reflecting an 18.3% increase from last year. Meanwhile, revenues are estimated at $290.48 million, marking a 16.6% rise compared to the same quarter a year ago.
Monitoring Earnings Estimates for Future Movements
Earnings and revenue expectations play a pivotal role when assessing stock potential. Research indicates a strong link between earnings estimate trends and stock price movements. In HealthEquity’s case, the consensus EPS forecast has remained steady over the past month. Typically, stock prices do not trend upwards without corresponding earnings estimate revisions, making it crucial for investors to watch HQY closely to determine if this recent increase can lead to sustained growth.
Current Stock Ranking and Industry Comparisons
The stock holds a Zacks Rank of #2 (Buy). On a related note, Embecta Corp. (EMBC), in the same medical services sector, ended its last session down 1.4% at $14.42, with a monthly return of 7.2%.
Embecta Corp. Sees Decline in Estimated Earnings
For Embecta Corp., the EPS estimate for the upcoming report has not changed over the past month and stands at $0.40, which is a 32.2% decrease compared to last year. Currently, Embecta has a Zacks Rank of #3 (Hold).
Expert Stock Selections for Future Gains
Experts have recently identified 7 elite stocks projected to perform well over the next 30 days from the current list of 220 Zacks Rank #1 (Strong Buy) stocks. Historically, this selection has outperformed the market significantly since 1988, boasting an average annual gain of 23.7%.
For the latest insights and recommendations from Zacks Investment Research, download the current list of “5 Stocks Set to Double.”
HealthEquity, Inc. (HQY): Free Stock Analysis Report
Embecta Corp. (EMBC): Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
The views and opinions expressed herein are those of the author and do not necessarily reflect those of Nasdaq, Inc.
